The FDA is getting AI-aggressive about speeding up device reviews. Its plan is to unleash generative AI on tedious and repetitive tasks.

Deerfield Management released details on its latest Healthcare Innovations Fund program, promising to finance “promising therapeutics” and “elevating emerging technologies," including artificial intelligence. 

In a lawsuit, plaintiffs allege the company changed course from a long-standing policy of denying medical claims, hiding from investors its impact on profits. The insurer denies any wrongdoing and vowed to defend itself in court. 

If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S. depending what rules are put in place.

Bloomberg writes about a company, Quick Health, run by a former comedy writer, who through a loophole in the law is accused of "hiring" members for fake jobs to enroll them in junk insurance policies.

Five Tenet Healthcare hospitals are suing the Leapfrog Group, accusing the organization of pressuring hospitals to share internal data in exchange for higher scores in its annual safety rankings. The watchdog outright denies the claim. 

The imaging manufacturer expects to spend between $227 million and $340 million on tariff mitigation efforts, leaders said Wednesday. 
 

For the second time in less than two years, the struggling retail pharmacy chain has filed for Chapter 11 bankruptcy protection, seeking buyers as it prepares for store closures.